Cargando…

EPEN-06. CHEMOTHERAPY OF RECURRENT EPENDYMOMA: LONG-TERM RESPONSE ONLY IN FEW CASES

INTRODUCTION: The efficacy of chemotherapy in recurrent ependymoma is unclear. We present results from the German HIT-REZ-studies. METHODS: 137 patients were analyzed regarding the treatment with chemotherapy at first recurrence, the time from first relapse to progression (PFS) and to either time-po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adolph, Jonas, Tippelt, Stephan, Mikasch, Ruth, Pfister, Stefan, Pajtler, Kristian, Witt, Hendrik, Witt, Olaf, Bison, Brigitte, Warmuth-Metz, Monika, Kortmann, Rolf-Dieter, Dietzsch, Stefan, Pietsch, Torsten, Timmermann, Beate, Fleischhack, Gudrun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Ependymoma
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715336/ http://dx.doi.org/10.1093/neuonc/noaa222.147

Ejemplares similares

EPEN-47. PEDS: PEDIATRIC EPENDYMOMA DISCOVERY STUDY
por: Smith, Amy, et al.
Publicado: (2020)

EPEN-39. CLINICAL STRATIFIED TREATMENT OF LOCALIZED PEDIATRIC INTRACRANIAL EPENDYMOMA WITH COMBINED LOCAL IRRADIATION AND CHEMOTHERAPY WITHIN THE PROSPECTIVE, MULTICENTER E-HIT TRIAL – THE MOLECULAR SUBGROUP MATTERS
por: von Hoff, Katja, et al.
Publicado: (2020)

EPEN-09. IMPACT OF MOLECULAR SUBGROUP ON OUTCOME FOR INFANTS <12 MONTHS WITH INTRACRANIAL EPENDYMOMA - GERMAN EXPERIENCE FROM HIT2000, INTERIM-2000-REGISTRY AND I-HIT-MED REGISTRY
por: Obrecht, Denise, et al.
Publicado: (2020)

EPEN-27. CDKN2A DELETION IN SUPRATENTORIAL EPENDYMOMA WITH RELA ALTERATION INDICATES A DISMAL PROGNOSIS – A RETROSPECTIVE ANALYSIS OF THE HIT EPENDYMOMA TRIAL COHORT
por: Jünger, Stephanie T, et al.
Publicado: (2020)

EPEN-28. Oncogenic dependency of pediatric ependymomas on extracellular vesicle pathways
por: Maass, Kendra K, et al.
Publicado: (2022)

Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies
por: Adolph, Jonas E., et al.
Publicado: (2021)

EPEN-36. THE TREATMENT OUTCOME OF PAEDIATRIC SUPRATENTORIAL C11ORF95-RELA FUSED EPENDYMOMA: A COMBINED REPORT FROM E-HIT SERIES AND AUSTRALIAN NEW ZEALAND CHILDREN’S HAEMATOLOGY/ONCOLOGY GROUP
por: Ng, Chia Huan, et al.
Publicado: (2020)

EPEN-44. EXTRACELLULAR VESICLES OF SUPRATENTORIAL EPENDYMOMA RELA MEDIATE INTERACTIONS WITH CELLS OF THE TUMOR MICROENVIRONMENT
por: Maass, Kendra K, et al.
Publicado: (2020)

EPEN-24. Biological markers of ependymoma in children and adolescents (BIOMECA): Systematic comparison of methods for the precise evaluation of biomarkers for ependymoma diagnosis and prognostication
por: Chapman, Rebecca, et al.
Publicado: (2022)

EPEN-06. CELL ECOSYSTEM AND SIGNALING PATHWAYS OF PRIMARY AND METASTATIC PEDIATRIC POSTERIOR FOSSA EPENDYMOMA
por: Aubin, Rachael, et al.
Publicado: (2021)

EPEN-01. MULTIDISCIPLINARY TREATMENT IN EPENDYMOMA
por: Hirokawa, Daisuke
Publicado: (2020)

EPEN-03. USP7 is an interaction partner of EZHIP and potential druggable target in PFA ependymomas
por: Jenseit, Anne, et al.
Publicado: (2022)

EPEN-04. ONCOGENIC 3D TUMOR GENOME ORGANIZATION IDENTIFIES NEW THERAPEUTIC TARGETS IN EPENDYMOMA
por: Okonechnikov, Konstantin, et al.
Publicado: (2020)

EPEN-18. Oncogenic 3D genome conformations identify novel therapeutic targets in ependymoma
por: Okonechnikov, Konstantin, et al.
Publicado: (2022)

EPEN-03. ZFTA/C11ORF95 FUSIONS DRIVE SUPRATENTORIAL EPENDYMOMA VIA SHARED ONCOGENIC MECHANISMS
por: Zheng, Tuyu, et al.
Publicado: (2021)

EPEN-05. Adenosine receptor expression in paediatric ependymoma
por: Spanoudakis, Chelsea, et al.
Publicado: (2022)

EPEN-16. TRANSCRIPTIONAL REGULATORY CIRCUITRIES AS MOLECULAR TARGETS IN EPENDYMOMA
por: Bertrand, Kelsey, et al.
Publicado: (2020)

EPEN-24. SIOP EPENDYMOMA II: CENTRAL EPENDYMOMA MANAGEMENT ADVISORY GROUP – THE UK EXPERIENCE
por: Macarthur, Donald C, et al.
Publicado: (2020)

EPEN-04. Refinement of molecular and clinical characteristics in a cohort of 1,801 ependymomas
por: Pohl, Lara, et al.
Publicado: (2022)

EPEN-21. IMPAIRED NEURONAL-GLIAL FATE SPECIFICATION IN PEDIATRIC EPENDYMOMA REVEALED BY SINGLE-CELL RNA-SEQ
por: Englinger, Bernhard, et al.
Publicado: (2020)

EPEN-18. CROSS-SPECIES GENOMICS IDENTIFIES GLI2 AS AN ONCOGENE OF C11orf95 FUSION-POSITIVE SUPRATENTORIAL EPENDYMOMA
por: Zheng, Tuyu, et al.
Publicado: (2020)

EPEN-35. PERITONEAL CARCINOMATOSIS OF ANAPLASTIC EPENDYMOMA: FIRST REPORTED CASE
por: Schwartz, Jonathan, et al.
Publicado: (2020)

EPEN-52. METABOLIC REGULATION OF THE EPIGENOME DRIVES LETHAL INFANTILE EPENDYMOMA
por: Kumar, Sachin, et al.
Publicado: (2020)

EPEN-37. TREATMENT OUTCOME OF RECURRENT EPENDYMOMA IN CHILDREN IN NORTHERN EGYPT
por: Fadel, Shady, et al.
Publicado: (2020)

EPEN-45. NORMALIZING AND FACILITATING GENOMIC TESTING AT DIAGNOSIS IN PEDIATRIC EPENDYMOMA
por: Pickle, Emily Owens, et al.
Publicado: (2020)

EPEN-31. Developmental and Oncogenic Transcription Factor Circuits as Dependencies in Ependymoma
por: Mack, Stephen
Publicado: (2022)

EPEN-03. LONG-TERM FOLLOW-UP OF AIEOP 2ND SERIES OF CHILDREN AND ADOLESCENT WITH PRIMARY INTRACRANIAL (ST:SUPRATENTORIAL; PF: POSTERIOR FOSSA) EPENDYMOMA AND METHYLATION GROUPS RE-ANALYSES
por: Massimino, Maura, et al.
Publicado: (2020)

EPEN-42. MOLECULAR PROFILING REVEALS DISTINCT SUBGROUPS OF PEDIATRIC SPINAL EPENDYMOMA
por: Ahmad, Omar, et al.
Publicado: (2020)

EPEN-51. CHILDHOOD INTRACRANIAL EPENDYMOMA: A MULTI-CENTER RETROSPECTIVE ANALYSIS
por: Pickle, Emily Owens, et al.
Publicado: (2020)

EPEN-23. A COMPUTATIONAL ANALYSIS OF THE TUMOUR IMMUNE MICROENVIRONMENT IN PAEDIATRIC EPENDYMOMA
por: Ritzmann, Timothy, et al.
Publicado: (2020)

EPEN-32. Leveraging cell surface targets as therapeutic vulnerabilities for pediatric ependymoma
por: Bertrand, Kelsey
Publicado: (2022)

EPEN-25. A novel spontaneous model of ZFTA-RELA fusion ependymoma
por: Bell, Sigourney, et al.
Publicado: (2022)

MEDB-17. Re-irradiation for recurrent medulloblastoma in a matched cohort: Advantageous especially in patients without resection
por: Adolph, Jonas E, et al.
Publicado: (2022)

EPEN-08. THE TREM1 POSITIVE HYPOXIC MYELOID SUBPOPULATION IN POSTERIOR FOSSA EPENDYMOMA
por: Willard, Nicholas, et al.
Publicado: (2021)

EPEN-11. TUMOR DIFFERENTIATION IMPACTS THE BIOLOGY OF RECURRENCE IN CHILDHOOD POSTERIOR FOSSA EPENDYMOMA
por: Donson, Andrew, et al.
Publicado: (2021)

EPEN-23. Interaction of epigenetic regulation and telomerase re-activation in high-risk ependymoma
por: Jaunecker, Carola N, et al.
Publicado: (2022)

EPEN-07. PATTERNS OF EXTRANEURAL METASTASES IN PEDIATRIC SUPRATENTORIAL EPENDYMOMA: CASE SERIES AND REVIEW OF THE LITERATURE
por: Chan, Priya P, et al.
Publicado: (2020)

EPEN-46. DNA METHYLATION LANDSCAPE OF RECURRENT PEDIATRIC EPENDYMOMA IDENTIFIES KEY DRIVER EVENTS
por: Zhao, Sibo, et al.
Publicado: (2020)

EPEN-27. Epigenetic dissection of spinal ependymomas (SP-EPN) separates tumors with and withoutNF2 mutation
por: Neyazi, Sina, et al.
Publicado: (2022)

EPEN-04. SIOP EPENDYMOMA I: FINAL RESULTS, LONG TERM FOLLOW-UP AND MOLECULAR ANALYSIS OF THE TRIAL COHORT: A BIOMECA CONSORTIUM STUDY
por: A. Ritzmann, Timothy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_74eahmfahlhq31paos7sq2fj7e